Stockchase Opinions

Norman Levine Cannabis Wheaton Income CBW-X DON'T BUY May 29, 2018

He hasn’t been a fan of marijuana stocks. Thinks its way too early. Some companies will be winners and the rest will be losers, and you still don’t know who the winners are going to be. The biggest problem is valuation, even Canopy’s CEO has been questioning valuation. You are starting to see officers and directors starting to leave cannabis companies knowing those stocks aren’t worth what they are, but being insiders they are being restricted from selling, and they actually have to leave to start selling, and we’re starting to see that.

$1.290

Stock price when the opinion was issued

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

Just announced 14 new streaming partners. The problem is that crops are inherently risky, and degrade with time. The companies are not approved, so where is the company going to get the finance to invest in desperate pre-approvals? The number of square feet of cannabis growth is going up. The problem is valuation.

DON'T BUY

He was skeptical earlier. They are going to help companies get approval in Canada. It has been going down for some time. He feels a lot of the smaller players are not going to make it.

COMMENT

They’ve put together an amazing team, and seems to have covered all the bases. What the Street and investors don’t like is all the murkiness behind who got the really, really cheap shares, and as to how much the stock price has gone up. Expects it will remain penalized for a while.